ADVFN Logo ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Dati di Mercato
Notizie
Utensili
Mercato
Scoprire

Caratteristiche principali

Follow Feed

Connettiti con trader e investitori nella nostra comunità Follow Feed.

Flusso di Opzioni

Esplora i dati completi sulle opzioni e utilizza filtri avanzati con Options Flow.

Monitor

Organizza e monitora la tua watchlist di azioni e attività con Monitor.
Accedi/Registrati Premium IconPremium Help Menu
Ftse Mib
39.204,43
-1,28%
DAX
23.002,18
-1,29%
S&P 500
5.683,72
0,15%
NASDAQ
17.807,33
0,32%
Bitcoin
84.456,86
-2,81%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati
  1. Home
  2. Investire
  3. Azioni
  4. U.S.A.
  5. NASDAQ
  6. Context Therapeutics Inc (CNTX)

  7. Context Therapeutics Inc (CNTX) Notizie

CNTX

Context Therapeutics (CNTX)

Context Therapeutics Inc
Da:
Ordina per:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CNTX
DataOraFonteTitoloSimboloCompagnia
28/02/202522:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNTXContext Therapeutics Inc
24/02/202523:05GlobeNewswire Inc.Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CNTXContext Therapeutics Inc
19/02/202513:30GlobeNewswire Inc.Context Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:CNTXContext Therapeutics Inc
14/02/202523:09Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CNTXContext Therapeutics Inc
14/02/202522:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CNTXContext Therapeutics Inc
14/01/202522:58GlobeNewswire Inc.Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76NASDAQ:CNTXContext Therapeutics Inc
13/01/202513:30GlobeNewswire Inc.Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of DirectorsNASDAQ:CNTXContext Therapeutics Inc
02/12/202422:20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CNTXContext Therapeutics Inc
15/11/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CNTXContext Therapeutics Inc
14/11/202423:05Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CNTXContext Therapeutics Inc
06/11/202422:42Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CNTXContext Therapeutics Inc
06/11/202422:06GlobeNewswire Inc.Context Therapeutics Reports Third Quarter 2024 Operating and Financial ResultsNASDAQ:CNTXContext Therapeutics Inc
06/11/202422:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CNTXContext Therapeutics Inc
23/10/202413:30GlobeNewswire Inc.Context Therapeutics to Participate in Upcoming Investor Conferences in NovemberNASDAQ:CNTXContext Therapeutics Inc
16/10/202413:30GlobeNewswire Inc.Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual MeetingNASDAQ:CNTXContext Therapeutics Inc
04/09/202413:30GlobeNewswire Inc.Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of DirectorsNASDAQ:CNTXContext Therapeutics Inc
07/08/202422:17GlobeNewswire Inc.Context Therapeutics Reports Second Quarter 2024 Operating and Financial ResultsNASDAQ:CNTXContext Therapeutics Inc
01/08/202423:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CNTXContext Therapeutics Inc
01/08/202413:30GlobeNewswire Inc.Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical OperationsNASDAQ:CNTXContext Therapeutics Inc
24/07/202423:07Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CNTXContext Therapeutics Inc
24/07/202422:55Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CNTXContext Therapeutics Inc
12/07/202422:04Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CNTXContext Therapeutics Inc
10/07/202413:30GlobeNewswire Inc.Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95NASDAQ:CNTXContext Therapeutics Inc
31/05/202422:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CNTXContext Therapeutics Inc
24/05/202422:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CNTXContext Therapeutics Inc
16/05/202422:01Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CNTXContext Therapeutics Inc
08/05/202422:06GlobeNewswire Inc.Context Therapeutics Reports First Quarter 2024 Operating and Financial ResultsNASDAQ:CNTXContext Therapeutics Inc
02/05/202413:31GlobeNewswire Inc.Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76NASDAQ:CNTXContext Therapeutics Inc
02/05/202413:30GlobeNewswire Inc.Context Therapeutics Announces $100 Million Private PlacementNASDAQ:CNTXContext Therapeutics Inc
01/04/202413:30GlobeNewswire Inc.Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive CancersNASDAQ:CNTXContext Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CNTX

La tua Cronologia

NASDAQ
AAL
American Airlines
BTRX
PLAUSD
PlayDapp Token
BOV
VLYB34
Valley National Bancorp
NYSE
SPIR
Spire Global
NYSE
AORT
Artivion
NASDAQ
CSX
CSX
AMEX
BITB
Bitwise Bitcoin ETF
LBNK
SUDOUSDT
SUDO GOVERNANCE TOKEN
AMEX
BITQ
Bitwise Crypto Industry ...
TG
49V
Vertiv
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
KHC
Kraft Heinz
NYSE
MOH
Molina Healthcare
NYSE
NET
Cloudflare
NYSE
BMA
Banco Macro
NYSE
SEI
Solaris Energy Infrastru...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Italia
Azienda
Attività
Popular
Ottieni l'app
App Store
Google Play

Assistenza: help@advfn.com

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

© 2025 ADVFN PLC - Tutti i diritti riservati

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci